VCA Antech (WOOF) - FREE Research Report

Drake Josh who is President, Antech Diagnostics at VCA Antech sold 2,199 shares at $33.87 on March 18, 2014. Following this transaction, the President, Antech Diagnostics owned 65,277 shares meaning that the stake was reduced by 3.26% with the 2,199-share transaction.

The shares most recently traded at $34.26, up $0.39, or 1.13% since the insider transaction. Historical insider transactions for VCA Antech go as follows:

  • 4-Week # shares sold: 5,267
  • 12-Week # shares sold: 5,267
  • 24-Week # shares sold: 5,267

The average volume for VCA Antech has been 563,600 shares per day over the past 30 days. VCA Antech has a market cap of $3.0 billion and is part of the services sector and diversified services industry. Shares are up 9.15% year-to-date as of the close of trading on Tuesday.

VCA Antech, Inc. operates as an animal healthcare company in the United States and Canada. It operates through two segments, Animal Hospital and Laboratory. The company has a P/E ratio of 22.3. Currently there are 4 analysts that rate VCA Antech a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WOOF - FREE

TheStreet Quant Ratings rates VCA Antech as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full VCA Antech Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Friday Selloff May Be On Its Way; Tenet Gears Up for Sale -- ICYMI

Dow Posts Fresh Record, Third in a Row, but S&P 500 and Nasdaq Fall